摘要
HomeRadiologyVol. 306, No. 1 PreviousNext CommunicationsLetters to the EditorRat Model of Hepatocellular Carcinoma for Better Understanding Immune Effects of Transarterial ChemoembolizationJulien Ghelfi*,†,§ , Thomas Decaens*,‡,§, Zuzana Macek Jilkova‡,§Julien Ghelfi*,†,§ , Thomas Decaens*,‡,§, Zuzana Macek Jilkova‡,§Author AffiliationsUniversité Grenoble Alpes, Saint-Martin-d’Hères, FranceDepartments of Radiology, CHU Grenoble Alpes, Boulevard de la Chantourne, 38700 La Tronche, FranceHepatology and Gastrointestinal Medical Oncology, CHU Grenoble Alpes, Boulevard de la Chantourne, 38700 La Tronche, FranceInstitute for Advanced Biosciences, INSERM U1209/CNRS UMR 5309, University of Grenoble-Alpes, La Tronche, Franceemail: [email protected]Julien Ghelfi*,†,§ Thomas Decaens*,‡,§Zuzana Macek Jilkova‡,§Published Online:Sep 6 2022https://doi.org/10.1148/radiol.220179MoreSectionsFull textPDF ToolsImage ViewerAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinked In References1. Tischfield DJ, Gurevich A, Johnson O, et al. Transarterial Embolization Modulates the Immune Response within Target and Nontarget Hepatocellular Carcinomas in a Rat Model. Radiology 2022;303(1):215–225. Link, Google Scholar2. de Baere T, Arai Y, Lencioni R, et al. Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion. Cardiovasc Intervent Radiol 2016;39(3):334–343. Crossref, Medline, Google Scholar3. Ye Y, Ren Y, Zeng H, He J, Zhong Z, Wu X. Characterization of Calibrated Gelatin Sponge Particles in a Rabbit Renal Embolization Model. Cardiovasc Intervent Radiol 2019;42(8):1183–1191. Crossref, Medline, Google Scholar4. Kurma K, Manches O, Chuffart F, et al. DEN-Induced Rat Model Reproduces Key Features of Human Hepatocellular Carcinoma. Cancers (Basel) 2021;13(19):4981. Crossref, Medline, Google Scholar5. Chen Z, Li S, Shen M, et al. The Mutational and Transcriptional Landscapes of Hepatocarcinogenesis in a Rat Model. iScience 2020;23(11):101690. Crossref, Medline, Google ScholarArticle HistoryPublished online: Sept 06 2022Published in print: Jan 2023 FiguresReferencesRelatedDetailsRecommended Articles Transarterial Embolization Modulates the Immune Response within Target and Nontarget Hepatocellular Carcinomas in a Rat ModelRadiology2022Volume: 303Issue: 1pp. 215-225The Immune Response: A New Frontier in Interventional OncologyRadiology2022Volume: 303Issue: 1pp. 229-230Adding Sorafenib-eluting Microspheres to TACE: The Next Step in Hepatocellular Carcinoma TreatmentRadiology: Imaging Cancer2021Volume: 3Issue: 1Is Idarubicin the Future of TACE?Radiology2019Volume: 291Issue: 3pp. 809-810Is There an Impact of Locoregional Therapy on Immune Response Modulation in HCC?Radiology2022Volume: 303Issue: 1pp. 226-228See More RSNA Education Exhibits Novel Embolic Agents On The HorizonDigital Posters2021Complications Of Locoregional Therapy In The Treatment Of Liver Malignancy: Adverse Events From Common To RareDigital Posters2021A Practical Guide of Locoregional Treatment for Patients with Hepatocellular CarcinomaDigital Posters2019 RSNA Case Collection LI-RADS 5RSNA Case Collection2022Radioembolization of Liver Metastasis RSNA Case Collection2020Gastric Antral Vascular EctasiaRSNA Case Collection2021 Vol. 306, No. 1 Metrics Altmetric Score PDF download